Susan M. Goodman, MD
Dr. Susan Goodman is a Rheumatologist at HSS. She specializes in treatment of patients with inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis, and spondylarthritis. Her other areas of specialization is in the perioperative care of patients with rheumatic diseases.
Research interests have focused on the perioperative outcomes of rheumatic disease patients undergoing arthroplasty.
Appointments
Associate Attending Physician, Hospital for Special Surgery
Associate Professor of Medicine, Weill Cornell Medical College
Specialty
Affiliations
Multi Specialty Peer Review Committee (MSPRC), co chair
Quality Coordinating Committee
Professional Safety Committee
Practice Effectiveness Committee
Director, Comprehensive Arthritis Clinical Research Program
Medical Chief, Comprehensive Arthritis Program (CAP)
Inflammatory Arthritis Center Steering Committee
Rehab Advisory Committee
Procedures
Arthrocentesis
Intra-Articular Injections
Soft Tissue Injections
Insurances Accepted
Blue Cross HMO POS
Blue Cross PPO
Medicare
Oxford
United Healthcare
If your particular insurance plan is not listed, you may still have coverage subject to the availability of 'out-of-network' benefits. Please do not hesitate to contact our office if you have questions regarding your insurance coverage.
Education
MD, University of Cincinnati
Internship
Lenox Hill Hospital, New York
Residency
Lenox Hill Hospital, New York
Fellowship
Columbia-Presbyterian Medical Center, New York
Certification
American Board of Internal Medicine, 1980
American Board of Internal Medicine/Rheumatology, 1982
State Licensure
New York
Susan M. Goodman, MD has contributed to the following educational materials:
For Patients - on HSS.edu
For Professionals - on HSS.edu
- The Use of Biologic DMARDS Identifies Rheumatoid Arthritis Patients with More Optimistic Expectations of Total Knee Arthroplasty
- First Time Myocardial Infarction in a Rheumatic Patient After Elective Arthroplasty
- Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: a Review of Risk Factors and Current Approaches to Diagnosis and Management
- Rhabdomyolysis is a Potential Complication of Total Hip Arthroplasty in the Morbidly Obese
- SAS Weekly Rounds: Avascular Necrosis
- Perioperative Management of Patients with Connective Tissue Disease
- Surgical Arthritis Service Weekly Rounds: Ankylosing Spondylitis
- Perioperative Management of Medications Used in the Treatment of Rheumatoid Arthritis
Selected Publications
Goodman SM. Rheumatoid arthritis: preoperative evaluation for total hip and total knee replacement surgery. J Clin Rheumatol 2013; Jun;19(4):187-92.
Goodman SM. Invited commentary. Sacroiliitis associated with axial spondyloarthropathy: new concepts and the latest trends. Radiographics 2013; Jul-Aug;33(4):956,8; discussion 959-61.
Goodman SM, Mackenzie CR. Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery. Curr Rheumatol Rep 2013; Sep;15(9):354,013-0354-y.
Johnson BK, Goodman SM, Alexiades MM, Figgie MP, Demmer RT, Mandl LA. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J Rheumatol 2013; May;40(5):617-23.
Stundner O, Chiu YL, Sun X, Goodman SM, Russell LA, Calloway JJ, et al. Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study. Clin Exp Rheumatol 2013; Nov 14
Stundner O, Danninger T, Chiu YL, Sun X, Goodman SM, Russell LA, et al. Rheumatoid Arthritis vs Osteoarthritis in Patients Receiving Total Knee Arthroplasty: Perioperative Outcomes. J Arthroplasty 2013; Jun 11;.
Kim SS, Perino G, Boettner F, Miller A, Goodman S. Salmonella septic arthritis of the knees in a patient with systemic lupus erythematosus. Lupus 2013; Jun;22(7):740-3.
Goodman SM, Perez-Aso M, Cronstein B. Wound Healing and Anti-Rheumatic Agents. ACR Drug Safety Quarterly 2013; vol 4 (3)
Goodman SM, Mandl LA, Johnson B, Huang W-, Figgie MP, Alexiades M, Ghomrawi H. The Use of Biologic DMARDS Identifies Rheumatoid Arthritis Patients with More Optimistic Expectations of Total Knee Arthroplasty HSSJ in press
For more publications, please see the PubMed listing.
Research Interests
perioperative outcomes of rheumatic disease patients undergoing arthroplasty
Clinical Trials
- Do Rheumatoid Arthritis Patients Undergoing TKR And THR Require More Transfusions and Have More Pulmonary Disease than OA Controls?
- The RA Biodam Study: Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
- A Study of Novel Immune Modulating Biomarkers in Patients with Spondyloarthritis with Axial Involvement
- Do SLE Patients have more Early Adverse Events within 6 Months of THR and TKR?
- Biomarkers in Spondyloarthropathies: A Case Control Study
Contact Information
Office Locations
Hospital for Special Surgery535 East 70th Street
New York, NY 10021
Tel: 212.606.1163
Fax: 212.472.6567
Mailing Address
Hospital for Special Surgery535 East 70th Street
New York, NY 10021